China’s Diabetes Race Heats Up As Novo Pins Hopes On Human Insulin EDL Inclusion; Lilly Calls For Faster Coverage

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.